Market news
Detailed price information for Trubridge Inc (TBRG-Q) from The Globe and Mail including charting and trades.
TruBridge is back in focus after analysts refreshed their price targets, with one valuation framework lifting fair value from US$22.00 to US$25.44, a change of about 15.6% in the model’s base case. Those updates are being framed around a mix of optimism and caution, as researchers weigh potential benefits from the proposed IKS transaction against execution and integration risks. As you read on, you will see how these shifting targets fit into the broader TruBridge story and how to keep track...
TruBridge (NASDAQ:TBRG) stockholders approved the company’s proposed merger agreement under which TruBridge will become a subsidiary of Inventurus Knowledge Solutions Inc., or IKS, during a virtual special meeting held July 7, 2026. Glenn Tobin, TruBridge’s Chairman of the Board, opened the meeting
Detailed price information for Trubridge Inc (TBRG-Q) from The Globe and Mail including charting and trades.
DALLAS & MOBILE, Ala., July 09, 2026--IKS Health, a global leader in care enablement solutions across the patient journey, today announced the successful completion of its previously announced acquisition of TruBridge™, Inc. TruBridge is a prominent provider of healthcare technology including an electronic health record (EHR) and revenue cycle management solutions for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health.
Detailed price information for Trubridge Inc (TBRG-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.